Perceptive Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$1.54M Hold
2024
Q1
$2.95M Buy
2023
Q1
Sell
2022
Q4
$13.5M Sell
2022
Q3
$21.8M Buy
2022
Q2
$7.91M Buy
2022
Q1
$2.68M Buy
2020
Q3
Sell
2020
Q2
$1.61M Sell
2020
Q1
$13.7M Buy
2019
Q4
$13.3M Buy
2018
Q2
Sell
2018
Q1
$19.1M Buy
2017
Q4
$14.3M Buy